Horger Marius, Hebart Holger, Einsele Hermann, Lengerke Claudia, Claussen C D, Vonthein Reinhard, Pfannenberg Christina
Department of Diagnostic Radiology, Eberhard-Karls-University, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany.
Eur J Radiol. 2005 Sep;55(3):437-44. doi: 10.1016/j.ejrad.2005.01.001. Epub 2005 Jan 28.
To assess early high-resolution computer tomographic (CT) signs of invasive pulmonary aspergillosis (IPA) in non-HIV immunosuppressed patients and their potential association with patient's outcome, including frequency and severity of pulmonary hemorrhage, taking also in consideration the impact of other known risk factors contributory to IPA.
A retrospective review of serial CT scans was performed in 45 immunocompromised patients with a total of 46 episodes of invasive pulmonary aspergillosis. All patients underwent CT beginning with the day they showed clinical or laboratory signs of infection. Serial follow-up CT included more than two, up to 12 CT examinations. Patient's outcome was judged by clinical and radiological follow-up and classified as survival, death by IPA, or death unrelated to IPA. The influence of patient's age, underlying disease, hematopoietic stem cell transplantation, neutropenia, graft versus host disease, and antifungal therapy onset was also statistically considered.
Three main CT findings were identified: small nodules (<1cm) 43% (20/46), large nodules 21% (10/46) and consolidations, either in patchy+/-segmental 26% (12/46), or peribronchial distribution+/-tree in bud 9% (4/46). In 11 patients (24%) we found a combination of two or more of these signs: 9 (19%) patients presented concurrent small nodules accompanied by reticulation, tree in bud or peribronchial infiltrates, while 2 (4%) patients showed large pulmonary nodules accompanied by large consolidations. An accompanying "halo" sign was observed in 38 patients (82%). Crescent sign followed by cavitation was encountered in 29 patients (63%). Two patients succumbed to massive pulmonary bleeding caused by IPA. Twenty-one patients (15/46) deceased in this series, 12 of them succumbed to IPA, 1 died from cerebral invasive aspergillosis, while in 9 patients the cause of death was not primarily IPA. Manifest pulmonary hemorrhage occurred in 19% (9/46) of IPA episodes.
Initial CT findings of invasive pulmonary aspergillosis consist mainly of small nodules or patchy consolidations, showing in 82% of cases an early halo sign. Serious pulmonary hemorrhage was an infrequent clinical complication in our series, with an attributable mortality of 4.3%. IPA-related lethality was 26%, in our cohort. None of the early HRCT signs seemed to predict outcome.
评估非HIV免疫抑制患者侵袭性肺曲霉病(IPA)的早期高分辨率计算机断层扫描(CT)征象及其与患者预后的潜在关联,包括肺出血的频率和严重程度,同时考虑其他已知的导致IPA的危险因素的影响。
对45例免疫功能低下患者共46次侵袭性肺曲霉病发作的系列CT扫描进行回顾性分析。所有患者从出现临床或实验室感染迹象之日起开始进行CT检查。系列随访CT包括两次以上、最多12次CT检查。通过临床和影像学随访判断患者的预后,并分为存活、死于IPA或死于与IPA无关的原因。还对患者年龄、基础疾病、造血干细胞移植、中性粒细胞减少、移植物抗宿主病和抗真菌治疗开始时间的影响进行了统计学分析。
确定了三个主要CT表现:小结节(<1cm)占43%(20/46),大结节占21%(10/46),实变,呈斑片状+/-节段性占26%(12/46),或支气管周围分布+/-芽生树占9%(4/46)。在11例患者(24%)中,我们发现了两种或更多这些征象的组合:9例(19%)患者同时出现小结节并伴有网状影、芽生树或支气管周围浸润,而2例(4%)患者表现为大的肺结节并伴有大片实变。38例患者(82%)观察到伴随的“晕”征。29例患者(63%)出现新月征并随后有空洞形成。2例患者死于IPA引起的大量肺出血。本系列中有21例患者(15/46)死亡,其中12例死于IPA,1例死于脑侵袭性曲霉病,而9例患者的死亡原因并非主要为IPA。19%(9/46)的IPA发作出现明显的肺出血。
侵袭性肺曲霉病的初始CT表现主要为小结节或斑片状实变,82%的病例显示早期晕征。严重肺出血在我们的系列中是一种罕见的临床并发症,归因死亡率为4.3%。在我们的队列中,IPA相关的致死率为26%。早期HRCT征象似乎均不能预测预后。